Studies on the vincamine-papaverine association. IV. Interference with beta-receptors in experimental animals.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D005260:Female; D007082:Ileum / Q000187:drug effects*; D008297:Male; D051379:Mice; D009130:Muscle, Smooth / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology*; D011188:Potassium / Q000494:pharmacology; D011817:Rabbits; D012701:Serotonin / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology; D014748:Vinca Alkaloids / Q000494:pharmacology*; D014749:Vincamine / Q000494:pharmacology*
D000319:Adrenergic beta-Antagonists; D014748:Vinca Alkaloids; D012701:Serotonin; D014749:Vincamine; D012964:Sodium; D010208:Papaverine; D011188:Potassium; D009638:Norepinephrine